Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Cash & Equivalents (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded Cash & Equivalents of $157.4 million in Q3 2026, down 21.8% from $201.25 million a year earlier but up 23.3% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Cash & Equivalents (2017 - 2026) Analysis & Trends

At the end of FY2025, Amneal Pharmaceuticals reported Cash & Equivalents of $282.03 million, up 155.1% from FY2024.

  • Annual Cash & Equivalents has increased for three straight years, though with a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • Across earlier years, Cash & Equivalents came in at $110.55 million in FY2024 (+20.8%), $91.54 million in FY2023 (+252.4%), $25.98 million in FY2022 (-89.5%) and $247.79 million in FY2021 (-27.4%).
  • Quarterly Cash & Equivalents has ranged from $25.98 million in Q4 2022 to $282.03 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Cash & Equivalents rose in seven of the last eight quarters, with growth averaging 91.1%.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 252.4% in Q4 2023, against a decline of 89.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $127.64 million (Q2 2026), $197.66 million (Q1 2026) and $282.03 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 157.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 157.40 Mn
Jun 30, 2026 127.64 Mn
Mar 31, 2026 197.66 Mn
Dec 31, 2025 282.03 Mn
Sep 30, 2025 201.25 Mn
Jun 30, 2025 71.54 Mn
Mar 31, 2025 59.19 Mn
Dec 31, 2024 110.55 Mn
Sep 30, 2024 74.01 Mn
Jun 30, 2024 43.77 Mn
Mar 31, 2024 46.52 Mn
Dec 31, 2023 91.54 Mn
Sep 30, 2023 86.93 Mn
Jun 30, 2023 109.28 Mn
Mar 31, 2023 144.67 Mn
Dec 31, 2022 25.98 Mn
Sep 30, 2022 87.34 Mn
Jun 30, 2022 91.98 Mn
Mar 31, 2022 210.48 Mn
Dec 31, 2021 247.79 Mn
API Access

Amneal Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMRX&period=max&api_key=YOUR_API_KEY